📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Biocatalysis in Drug Design: Engineered Reductive Aminases (RedAms) Are Used to Access Chiral Building Blocks with Multiple Stereocenters. (2023)

First Author: Casamajo AR

Attributed to: Centre for Biocatalytic Manufacture of New Modalities (CBNM) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/jacs.3c07010

PubMed Identifier: 37782882

Publication URI: http://europepmc.org/abstract/MED/37782882

Type: Journal Article/Review

Volume: 145

Parent Publication: Journal of the American Chemical Society

Issue: 40

ISSN: 0002-7863